Point of Care Diagnostics Testing Market Analysis

ID: MRFR/HC/9161-HCR

120 Pages

Rahul Gotadki

September 2025

Point of Care Diagnostics Testing Market By Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Cancer/Tumor Marker Testing, Urinalysis Testing, Cholesterol, Drugs-of-Abuse Testing), By End User (Hospitals & Clinics, Diagnostic Centers, Homecare/Self Testing), By Mode of Purchase...

Point of Care Diagnostics Testing Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Market Analysis

In-depth Analysis of Point of Care Diagnostics Testing Market Industry Landscape

There has been a significant evolution in the market dynamics for Point-Of-Care Diagnostics/ Testing (POCT), completely transforming medical diagnostics. The term "point-of-care" refers to tests performed near patients, producing quick results that inform immediate clinical decisions. The need for faster and more convenient diagnostic solutions is one of the major factors driving growth in the POCT market. Traditionally, laboratory-based testing was characterized by lengthy procedures and delays before results were presented. Decentralization of healthcare services has played a key role in shaping the growth of the POCT market. As healthcare delivery models shift towards more community-based and patient-centric approaches, the demand for point-of-care testing has increased. POCT allows healthcare professionals to carry out diagnostic tests in various settings, including physician offices, clinics, pharmacies, or even at home. Technological advancements have been a driving force behind innovative POCT solutions. The development of portable and user-friendly testing platforms has been achieved through the miniaturization of diagnostic devices and the integration of microfluidics as well as biomolecules. Application of biosensors coupled with miniaturization techniques and microfluidic systems has enabled the production of portable and easy-to-use diagnostics. Market competition between established companies and newcomers has become fiercer, with both aiming to claim their part of the growing POCT market. Well-established diagnostic firms are expanding their portfolios on POCT through acquisitions or collaborations, while new startups bring about unique technologies along with devices. The emergence of the COVID-19 pandemic has greatly influenced these dynamics, resulting in changes within this sector. The global spread of the virus necessitates fast, widespread test administration to identify and control its spread, thus leading to an increase in demand for point-of-care test solutions. Regulatory considerations highly influence the market dynamics of POCT. For the safety and efficiency of point-of-care diagnostic devices, regulators around the world have established standards and guidelines. Getting approvals from regulators is a critical move for manufacturers because it influences product development timelines and entry into the market. The regulatory framework has also been evolving in line with peculiar challenges and opportunities presented by point-of-care testing. Also, the market dynamics of POCT depend on cost-effectiveness. In view of this, affordable point-of-care solutions are increasingly being sought as value-based healthcare gains ground. This aspect is crucial, especially in areas characterized by scarcity of resources or where healthcare decisions are greatly affected by the costs involved.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

The Global Point of Care Diagnostics Testing Market is projected to experience substantial growth from 57.7 USD Billion in 2024 to 157.9 USD Billion by 2032.

Key Market Trends & Highlights

Point of Care Diagnostics Testing Key Trends and Highlights

The market is expected to grow at a compound annual growth rate of 9.58 percent from 2025 to 2032. By 2035, the market valuation is anticipated to reach 157.9 USD Billion, indicating a robust expansion. In 2024, the market is valued at 57.7 USD Billion, reflecting a strong foundation for future growth. Growing adoption of point of care diagnostics due to increasing demand for rapid and accurate testing is a major market driver.

Point of Care Diagnostics Testing Market

CAGR

9.58%

Market Size & Forecast

2024 Market Size	57.7 (USD Billion)
2035 Market Size	157.9 (USD Billion)
CAGR (2025-2035)	9.58%
Largest Regional Market Share in 2024	latin_america)

Major Players

Abbott Laboratories (US), Chembio Diagnostics, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Siemens Healthineers GmbH (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), Instrumentation Laboratory Company (Werfen) (US), EKF Diagnostics Holdings plc (UK)

Market Trends

Drivers

Increasing demand for COVID-19 POC test kits

The Global Point of Care Diagnostics Testing Market is poised for substantial growth, driven by advancements in technology and an increasing demand for rapid diagnostic solutions in various healthcare settings.

U.S. Food and Drug Administration (FDA)

Point of Care Diagnostics Testing Market Market Drivers

Market Trends and Projections

Government Initiatives and Funding

Government initiatives and funding significantly impact the Global Point of Care Diagnostics Testing Market Industry, as various health authorities recognize the importance of accessible diagnostic solutions. Investments in point-of-care technologies are being prioritized to improve healthcare delivery, particularly in underserved regions. Programs aimed at enhancing diagnostic infrastructure and training healthcare professionals are being implemented globally. These initiatives not only foster innovation but also encourage collaboration between public and private sectors, ultimately driving market growth. As governments continue to support point-of-care diagnostics, the industry is poised for expansion, aligning with global health objectives.

Shift Towards Home Healthcare Services

The Global Point of Care Diagnostics Testing Market Industry is witnessing a notable shift towards home healthcare services, driven by the increasing preference for at-home testing and monitoring. Patients are increasingly opting for convenient testing options that allow them to manage their health from the comfort of their homes. This trend is supported by advancements in telemedicine and mobile health technologies, which facilitate remote consultations and data sharing. As a result, the market is likely to expand, with projections indicating a compound annual growth rate of 9.58% from 2025 to 2035, reflecting the growing acceptance of home-based diagnostic solutions.

Increasing Prevalence of Chronic Diseases

The Global Point of Care Diagnostics Testing Market Industry is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases. As these conditions require continuous monitoring and management, point-of-care testing offers a practical solution for patients and healthcare providers. The ability to conduct tests in various settings, including home care and remote locations, enhances patient compliance and engagement in their health management. This trend is expected to propel market growth, as the demand for accessible and efficient diagnostic solutions continues to rise in response to the global health landscape.

Rising Demand for Rapid Testing Solutions

The Global Point of Care Diagnostics Testing Market Industry experiences a surge in demand for rapid testing solutions, driven by the need for timely diagnosis and treatment. Healthcare providers increasingly prefer point-of-care testing due to its ability to deliver results within minutes, facilitating quicker clinical decisions. This trend is particularly evident in emergency departments and outpatient settings, where immediate test results can significantly impact patient outcomes. The market is projected to reach 57.7 USD Billion in 2024, reflecting a growing recognition of the value of rapid diagnostics in enhancing healthcare efficiency and patient care.

Technological Advancements in Diagnostic Devices

Technological innovations play a crucial role in the Global Point of Care Diagnostics Testing Market Industry, with advancements in microfluidics, biosensors, and mobile health applications enhancing diagnostic capabilities. These technologies enable the development of more accurate, user-friendly, and portable testing devices. For instance, the integration of artificial intelligence in diagnostic tools is streamlining data analysis and improving result accuracy. As these technologies evolve, they are expected to drive market growth, contributing to an anticipated increase in market value to 157.9 USD Billion by 2035, as healthcare systems worldwide adopt more sophisticated point-of-care solutions.

Market Segment Insights

Point of Care Diagnostics Testing Product Insights

Point of Care Diagnostics Testing End User Insights

Point of Care Diagnostics Testing Mode of Purchase Insights

Point of Care Diagnostics Testing Platform Insights

Get more detailed insights about Point of Care Diagnostics Testing Market Research Report - Global Forecast till 2032

Regional Insights

Key Companies in the Point of Care Diagnostics Testing Market market include

Industry Developments

In June 2021,DCN Dx(US) acquired the pointofcare diagnostics development company PortaScience Inc. (US). This acquisition will expand the point of care product portfolio of the company.
In April 2021,the Indian Institute of Technology Kharagpur (India), an Indian engineering institute,launched a nucleic acid-based pointof care diagnostic devicefor COVID-19 diagnosis.
In April 2021,LumiraDx (US), a next-generation point of care diagnostics testing company,announced its merger with CA Healthcare Acquisition (CAHC) (US)in a deal worth USD 5 billion.
In March 2021, MatMaCorp (US) launched MYRTA, a handheld real-time POCPCR device for molecular diagnostics.
In March 2020, Abbott(US) launched the fastest available molecular pointofcare test to detect the coronavirus in less than 5 minutes.

Future Outlook

Point of Care Diagnostics Testing Market Future Outlook

The Global Point of Care Diagnostics Testing Market is projected to grow at a 9.58% CAGR from 2024 to 2032, driven by technological advancements, increasing demand for rapid testing, and rising healthcare expenditures.

New opportunities lie in:

Develop portable diagnostic devices for remote healthcare settings. Invest in AI-driven analytics for enhanced diagnostic accuracy. Expand partnerships with telehealth platforms to integrate testing solutions.

By 2035, the market is expected to achieve substantial growth, reflecting a robust demand for innovative diagnostic solutions.

Market Segmentation

Point of Care Diagnostics Testing Product Outlook

{""=>["Strips"
"Meters"
"Lancets"]}
{""=>["Cardiac Marker Testing Products"
"Blood Gas/Electrolyte Testing Products"
"HbA1c Testing Products"]}
{""=>["HIV Testing "
"Respiratory Infection Testing"
"Hepatitis Testing"
"Sexually Transmitted Disease Testing"
"Others"]}
{""=>["PT/INR Testing"
"ACT/APTT Testing"]}

Point of Care Diagnostics Testing End User Outlook

Hospitals & Clinics
Diagnostic Centers
Homecare/Self Testing
Others

Point of Care Diagnostics Testing Platform Outlook

Immunoassays
Molecular Diagnostics
Dipsticks
Others

Point of Care Diagnostics Testing Mode of Purchase Outlook

OTC Testing Products
Prescription-based testing products

Report Scope

Report Attribute/Metric	Details
Market Size 2023	52.70 (USD Billion)
Market Size 2024	57.71 (USD Billion)
Market Size 2032	119.36 (USD Billion)
Compound Annual Growth Rate (CAGR)	9.77 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2018-2022
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Abbott Laboratories (US),Siemens Healthineers GmbH (Germany),Chembio Diagnostics, Inc.(US),Hoffmann-La Roche Ltd (Switzerland),Johnson & Johnson Services, Inc. (US),Becton, Dickinson and Company (US),Danaher Corporation (US),PTS Diagnostics (US),Nova Biomedical (US),QuidelCorporation (US)
Key Market Opportunities	Increasing healthcare issues increasing population diagnosed
Key Market Drivers	Increasing demand for COVID-19 POC test kits Risingnumber of chronic disease cases across the globe

Market Highlights

Author

Rahul Gotadki

Assistant Manager

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

[email protected]

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

[email protected]

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

What is the CAGR for Point of Care Diagnostics Testing Market?

The Point of Care Diagnostics/Testing Market can expand at 9.77% CAGR by 2032.

Who are key players of the Point of Care Diagnostics Testing Market?

Abbott Laboratories (US),Siemens Healthineers GmbH (Germany),Chembio Diagnostics, Inc.(US),Hoffmann-La Roche Ltd (Switzerland),Johnson & Johnson Services, Inc. (US),Becton, Dickinson and Company (US),Danaher Corporation (US),PTS Diagnostics (US),Nova Biomedical (US),QuidelCorporation (US) Are the key players of market

What is the valuation of the Point of Care Diagnostics Testing Market?

By 2032, the Point of Care Diagnostics/Testing Market value can exceed USD 119.36 Billion.

What is the Point of Care Diagnostics Testing Market driver?

Increasing demand for COVID-19 POC test kits is driving the Point of Care Diagnostics/Testing Market.

What is the Point of Care Diagnostics Testing Market restrain?

Increases the potential of rapid medical diagnosis restrain the Point of Care Diagnostics/Testing Market.

--- "TABLE OF CONTENTS
REPORT PROLOGUE
MARKET INTRODUCTION
1. Definition
2. Scope of the Study
  1. Research Objective
  2. Assumptions
  3. Limitations
RESEARCH METHODOLOGY
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
  1. Primary Interviews and Information Gathering Process
  2. Breakdown of Primary Respondents
5. Forecasting Cellulite Type
6. Market Size Estimation
  1. Bottom-Up Approach
  2. Top-Down Approach
7. Data Triangulation
8. Validation
MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
MARKET FACTOR ANALYSIS
1. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
2. Value Chain Analysis
3. COVID-19 Impact Analysis
  1. Market Impact Analysis
  2. Impact on Supply Chain
  3. Regional Impact
  4. Opportunity and Threat Analysis
GLOBAL Point of Care Diagnostics Testing MARKET, BY PRODUCT
1. Overview
2. Glucose Monitoring
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
1. Strips
  1. Meters
  2. Lancets
2. Cardiometabolic Monitoring
  1. Cardiac Marker Testing Products
  2. Blood Gas/Electrolyte Testing Products
  3. HbA1c Testing Products
3. Infectious Disease Testing
  1. HIV Testing
  2. Respiratory Infection Testing
  3. Hepatitis Testing
  4. Sexually Transmitted Disease Testing
  5. Others
4. Coagulation Monitoring
  1. PT/INR Testing
  2. ACT/APTT Testing
5. Pregnancy & Fertility Testing
6. Hematology Testing
7. Cancer/Tumor Marker Testing
8. Urinalysis Testing
9. Cholesterol
10. Drugs-of-Abuse Testing
11. Others
GLOBAL Point of Care Diagnostics Testing MARKET, BY END USER
1. Overview
2. Hospitals & Clinics
3. Diagnostic Centers
4. Homecare/Self Testing
5. Others
GLOBAL Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE
1. Overview
2. OTC Testing Products
3. Prescription-based testing products
GLOBAL Point of Care Diagnostics Testing MARKET, BY PLATFORM
1. Overview
2. Immunoassays
3. Dipsticks
4. Molecular Diagnostics
5. Others
GLOBAL Point of Care Diagnostics Testing MARKET, BY REGION
1. Overview
2. North America
  1. US
  2. Canada
3. Europe
  1. Germany
  2. France
  3. UK
  4. Italy
  5. Spain
  6. Rest of Europe
4. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. Rest of Asia-Pacific
5. Rest of the World
  1. Middle East
  2. Africa
  3. Latin America
COMPANY LANDSCAPE
1. Overview
2. Competitive Analysis
3. Market Share Analysis
4. Major Growth Strategy in the Global Point of Care Diagnostics Testing Market
5. Competitive Benchmarking
6. Leading Players in Terms of Number of Developments in the Global Point of Care Diagnostics Testing Market
7. Key developments and Growth Strategies
  1. New ProductLaunch/Service Deployment
  2. Merger &Acquisitions
  3. Joint Ventures
8. Major Players Financial Matrix
  1. Sales & Operating Income, 2020
  2. Major Players R&D Expenditure, 2020
COMPANY PROFILES
1. Abbott Laboratories
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
2. Siemens Healthineers GmbH
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
3. Chembio Diagnostics, Inc.
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
4. F. Hoffmann-La Roche Ltd
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
5. Johnson & Johnson Services, Inc.
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
6. Becton, Dickinson and Company
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
7. Danaher Corporation
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
8. PTS Diagnostics
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
9. Nova Biomedical
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
10. Quidel Corporation
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
11. Sekisui Diagnostics
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
12. Trinity Biotech
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
13. AccuBioTech Co., Ltd.
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
14. Instrumentation Laboratory Company (Werfen)
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
15. EKF Diagnostics Holdings plc
  1. Company Overview
  2. Product Offered
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
APPENDIX
1. References
2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL Point of Care Diagnostics Testing MARKET SYNOPSIS, 2022–2030
TABLE 2 GLOBAL Point of Care Diagnostics Testing MARKET ESTIMATES &FORECAST, 2022–2030(USD MILLION)
TABLE 3 GLOBAL Point of Care Diagnostics Testing MARKET, BYPRODUCT, 2022–2030 (USD MILLION)
TABLE 4 GLOBAL Point of Care Diagnostics Testing MARKET, BY END USER,2022–2030 (USD MILLION)
TABLE 5 GLOBAL Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 6 GLOBAL Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 7 NORTH AMERICA OF CARE DIAGNOSTICS/TESTING MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 8 NORTH AMERICAPoint of Care Diagnostics Testing MARKET, BY END USER,2022–2030 (USD MILLION)
TABLE 9 NORTH AMERICAPoint of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 10 NORTH AMERICAPoint of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 11 US: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 12 US Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 13 US: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 14 US: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 15 CANADA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 16 CANADA Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 17 CANADA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 18 CANADA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 19 EUROPE: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 20 EUROPE: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 21 EUROPE: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 22 EUROPE: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 23 GERMANY: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 24 GERMANY: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 25 GERMANY: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 26 GERMANY: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 27 FRANCE: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 28 FRANCE: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 29 FRANCE: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 30 FRANCE: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 31 UK: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 32 UK: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 33 UK: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 34 UK: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 35 ITALY: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 36 ITALY: Point of Care Diagnostics Testing MARKET, BY END USER2022–2030 (USD MILLION)
TABLE 37 ITALY: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 38 ITALY: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 39 SPAIN: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 40 SPAIN: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 41 SPAIN: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 42 SPAIN: Point of Care Diagnostics Testing MARKET, BYPLATFORM2022–2030 (USD MILLION)
TABLE 43 REST OF EUROPE: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 44 REST OF EUROPE: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 45 REST OF EUROPE: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 46 REST OF EUROPE: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 51 CHINA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 52 CHINA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 53 CHINA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 54 CHINA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 55 INDIA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 56 INDIA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 57 INDIA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 58 INDIA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 59 JAPAN: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 60 JAPAN: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 61 JAPAN: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 62 JAPAN: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 63 SOUTH KOREA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 64 SOUTH KOREA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 65 SOUTH KOREA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 66 SOUTH KOREA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 67 AUSTRALIA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 68 AUSTRALIA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 69 AUSTRALIA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 70 AUSTRALIA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 71 REST OF ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 72 REST OF ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 73 REST OF ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 75 REST OF WORLD: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 76 REST OF WORLD: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 77 REST OF WORLD: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 78 REST OF WORLD: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 79 MIDDLE EAST: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 80 MIDDLE EAST: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 81 MIDDLE EAST: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 82 MIDDLE EAST: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 83 AFRICA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 84 AFRICA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 85 AFRICA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 86 AFRICA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
TABLE 87 LATIN AMERICA: Point of Care Diagnostics Testing MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 88 LATIN AMERICA: Point of Care Diagnostics Testing MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 89 LATIN AMERICA: Point of Care Diagnostics Testing MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION)
TABLE 90 LATIN AMERICA: Point of Care Diagnostics Testing MARKET, BY PLATFORM, 2022–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL POINT OF CAREDIAGNOSTICS/TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL Point of Care Diagnostics Testing MARKET
FIGURE 4 GLOBAL Point of Care Diagnostics Testing MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 5 GLOBAL Point of Care Diagnostics Testing MARKET SHARE, BY END USER, 2020 (%)
FIGURE 6 GLOBAL Point of Care Diagnostics Testing MARKET SHARE, BY MODE OF PURCHASE, 2020 (%)
FIGURE 7 GLOBAL Point of Care Diagnostics Testing MARKET SHARE, BY PLATFORM, 2020 (%)
FIGURE 8 GLOBAL Point of Care Diagnostics Testing MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICAPoint of Care Diagnostics Testing MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 10 NORTH AMERICAPoint of Care Diagnostics Testing MARKET SHARE, BY END USER, 2020 (%)
FIGURE 11 NORTH AMERICAPoint of Care Diagnostics Testing MARKET SHARE, BY MODE OF PURCHASE, 2020 (%)
FIGURE 12 NORTH AMERICAPoint of Care Diagnostics Testing MARKET SHARE, BY PLATFORM, 2020 (%)
FIGURE 13 EUROPEPoint of Care Diagnostics Testing MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 14 EUROPEPoint of Care Diagnostics Testing MARKET SHARE, BY END USER, 2020 (%)
FIGURE 15 EUROPEPoint of Care Diagnostics Testing MARKET SHARE, BY MODE OF PURCHASE, 2020 (%)
FIGURE 16 EUROPEPoint of Care Diagnostics Testing MARKET SHARE, BY PLATFORM, 2020 (%)
FIGURE 17 ASIA-PACIFICPoint of Care Diagnostics Testing MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 18 ASIA-PACIFICPoint of Care Diagnostics Testing MARKET SHARE, BY END USER, 2020 (%)
FIGURE 19 ASIA-PACIFICPoint of Care Diagnostics Testing MARKET SHARE, BY MODE OF PURCHASE, 2020 (%)
FIGURE 20 ASIA-PACIFICPoint of Care Diagnostics Testing MARKET SHARE, BY PLATFORM, 2020 (%)
FIGURE 21 REST OF THE WORLDPoint of Care Diagnostics Testing MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 22 REST OF THE WORLD Point of Care Diagnostics Testing MARKET SHARE, BY END USER, 2020 (%)
FIGURE 23 REST OF THE WORLDPoint of Care Diagnostics Testing MARKET SHARE, BY MODE OF PURCHASE, 2020 (%)
FIGURE 24 REST OF THE WORLD Point of Care Diagnostics Testing MARKET SHARE, BY PLATFORM, 2020 (%)
FIGURE 25 ABBOTT LABORATORIES .: KEY FINANCIALS
FIGURE 26 ABBOTT LABORATORIES : SEGMENTAL REVENUE
FIGURE 27 ABBOTT LABORATORIES : REGIONAL REVENUE
FIGURE 28 SIEMENS HEALTHINEERS GMBH : KEY FINANCIALS
FIGURE 29 SIEMENS HEALTHINEERS GMBH : SEGMENTAL REVENUE
FIGURE 30 SIEMENS HEALTHINEERS GMBH : REGIONAL REVENUE
FIGURE 31 CHEMBIO DIAGNOSTICS, INC. : KEY FINANCIALS
FIGURE 32 CHEMBIO DIAGNOSTICS, INC. : SEGMENTAL REVENUE
FIGURE 33 CHEMBIO DIAGNOSTICS, INC. : REGIONAL REVENUE
FIGURE 34 F. HOFFMANN-LA ROCHE LTD.: KEY FINANCIALS
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: SEGMENTAL REVENUE
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: REGIONAL REVENUE
FIGURE 37 JOHNSON & JOHNSON SERVICES, INC. : KEY FINANCIALS
FIGURE 38 JOHNSON & JOHNSON SERVICES, INC. : SEGMENTAL REVENUE
FIGURE 39 JOHNSON & JOHNSON SERVICES, INC. : REGIONAL REVENUE
FIGURE 40 BECTON, DICKINSON AND COMPANY : KEY FINANCIALS
FIGURE 41 BECTON, DICKINSON AND COMPANY : SEGMENTAL REVENUE
FIGURE 42 BECTON, DICKINSON AND COMPANY : REGIONAL REVENUE
FIGURE 43 DANAHER CORPORATION : KEY FINANCIALS
FIGURE 44 DANAHER CORPORATION : SEGMENTAL REVENUE
FIGURE 45 DANAHER CORPORATION : REGIONAL REVENUE
FIGURE 46 PTS DIAGNOSTICS: KEY FINANCIALS
FIGURE 47 PTS DIAGNOSTICS: SEGMENTAL REVENUE
FIGURE 48 PTS DIAGNOSTICS: REGIONAL REVENUE
FIGURE 49 NOVA BIOMEDICAL : KEY FINANCIALS
FIGURE 50 NOVA BIOMEDICAL : SEGMENTAL REVENUE
FIGURE 51 NOVA BIOMEDICAL : REGIONAL REVENUE
FIGURE 52 QUIDEL CORPORATION : KEY FINANCIALS
FIGURE 53 QUIDEL CORPORATION : SEGMENTAL REVENUE
FIGURE 54 QUIDEL CORPORATION : REGIONAL REVENUE
FIGURE 55 SEKISUI DIAGNOSTICS : KEY FINANCIALS
FIGURE 56 SEKISUI DIAGNOSTICS : SEGMENTAL REVENUE
FIGURE 57 SEKISUI DIAGNOSTICS : REGIONAL REVENUE
FIGURE 58 TRINITY BIOTECH : KEY FINANCIALS
FIGURE 59 TRINITY BIOTECH : SEGMENTAL REVENUE
FIGURE 60 TRINITY BIOTECH : REGIONAL REVENUE
FIGURE 61 ACCUBIOTECH CO., LTD.: KEY FINANCIALS
FIGURE 62 ACCUBIOTECH CO., LTD.: SEGMENTAL REVENUE
FIGURE 63 ACCUBIOTECH CO., LTD.: REGIONAL REVENUE
FIGURE 64 INSTRUMENTATION LABORATORY COMPANY (WERFEN): KEY FINANCIALS
FIGURE 65 INSTRUMENTATION LABORATORY COMPANY (WERFEN): SEGMENTAL REVENUE
FIGURE 66 INSTRUMENTATION LABORATORY COMPANY (WERFEN): REGIONAL REVENUE
FIGURE 67 EKF DIAGNOSTICS HOLDINGS PLC: KEY FINANCIALS
FIGURE 68 EKF DIAGNOSTICS HOLDINGS PLC: SEGMENTAL REVENUE
FIGURE 69 EKF DIAGNOSTICS HOLDINGS PLC: REGIONAL REVENUE"

Point of Care Diagnostics Testing Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027